281 related articles for article (PubMed ID: 34149613)
1. How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.
Zhao X; Feng X; Zhao X; Jiang Y; Li X; Niu J; Meng X; Wu J; Xu G; Hou L; Wang Y
Front Endocrinol (Lausanne); 2021; 12():659268. PubMed ID: 34149613
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
[TBL] [Abstract][Full Text] [Related]
3. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
[TBL] [Abstract][Full Text] [Related]
4. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study.
Chen X; Lu T; Wang X; Sun X; Zhang J; Zhou K; Ji X; Sun R; Wang X; Chen M; Ling X
Clin Chim Acta; 2020 Mar; 502():280-286. PubMed ID: 31758934
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight.
Diboun I; Ramanjaneya M; Ahmed L; Bashir M; Butler AE; Albagha O; Abou-Samra AB; Atkin SL; Mazloum NA; Elrayess MA
Front Endocrinol (Lausanne); 2021; 12():638727. PubMed ID: 34211435
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach.
Dong F; Deng D; Chen H; Cheng W; Li Q; Luo R; Ding S
Anal Bioanal Chem; 2015 Jun; 407(16):4683-95. PubMed ID: 25860656
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Biomarkers for Urine Metabolomics of Polycystic Ovary Syndrome Based on Gas Chromatography-Mass Spectrometry.
Zou Y; Zhu FF; Fang CY; Xiong XY; Li HY
Chin Med J (Engl); 2018 Apr; 131(8):945-949. PubMed ID: 29664055
[TBL] [Abstract][Full Text] [Related]
8. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry.
Vonica CL; Ilie IR; Socaciu C; Moraru C; Georgescu B; Farcaş A; Roman G; Mureşan AA; Georgescu CE
Scand J Clin Lab Invest; 2019 Oct; 79(6):437-442. PubMed ID: 31462125
[TBL] [Abstract][Full Text] [Related]
9. Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry.
Jia C; Xu H; Xu Y; Xu Y; Shi Q
Mol Reprod Dev; 2019 Mar; 86(3):292-297. PubMed ID: 30624822
[TBL] [Abstract][Full Text] [Related]
10. UPLC/Q‑TOF‑MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome.
Fan X; Jiang J; Huang Z; Gong J; Wang Y; Xue W; Deng Y; Wang Y; Zheng T; Sun A; Luo G
Mol Med Rep; 2019 Jan; 19(1):280-292. PubMed ID: 30431132
[TBL] [Abstract][Full Text] [Related]
11. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
12. Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS.
Wang W; Wang S; Tan S; Wen M; Qian Y; Zeng X; Guo Y; Yu C
Clin Chim Acta; 2015 Aug; 448():39-47. PubMed ID: 26093338
[TBL] [Abstract][Full Text] [Related]
13. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome.
Rasool SUA; Ashraf S; Nabi M; Rashid F; Fazili KM; Amin S
Diabetes Metab Syndr; 2019; 13(3):2098-2105. PubMed ID: 31235143
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure.
Chen J; Zhou Q; Zhang Y; Tan W; Gao H; Zhou L; Xiao S; Gao J; Li J; Zhu Z
Bioengineered; 2021 Dec; 12(1):8778-8792. PubMed ID: 34696698
[TBL] [Abstract][Full Text] [Related]
15. Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.
Rizzo M; Longo RA; Guastella E; Rini GB; Carmina E
J Endocrinol Invest; 2011 Jun; 34(6):422-6. PubMed ID: 20959718
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry.
Sun Z; Chang HM; Wang A; Song J; Zhang X; Guo J; Leung PCK; Lian F
Reprod Biol Endocrinol; 2019 Jun; 17(1):45. PubMed ID: 31186025
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.
Zhang Z; Hong Y; Chen M; Tan N; Liu S; Nie X; Zhou W
Metabolomics; 2020 Jan; 16(2):20. PubMed ID: 31980950
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome.
Hou E; Zhao Y; Hang J; Qiao J
Biomed Chromatogr; 2021 Mar; 35(3):e4993. PubMed ID: 32986877
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry.
Zhao X; Xu F; Qi B; Hao S; Li Y; Li Y; Zou L; Lu C; Xu G; Hou L
J Proteome Res; 2014 Feb; 13(2):1101-11. PubMed ID: 24428203
[TBL] [Abstract][Full Text] [Related]
20. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
